Cargando…
A comparison of office-based buprenorphine treatment outcomes in Bronx community clinics before versus during the COVID-19 pandemic
INTRODUCTION: In 2020, the US and New York City experienced unprecedented deaths due to the COVID-19 pandemic and drug overdoses. Policy changes reduced burdensome regulations for medication treatment for opioid use disorder (OUD). Despite these policy changes, few studies examined buprenorphine tre...
Autores principales: | Cunningham, Chinazo O., Khalid, Laila, Deng, Yuting, Torres-Lockhart, Kristine, Masyukova, Mariya, Thomas, Shenell, Zhang, Chenshu, Lu, Tiffany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550890/ https://www.ncbi.nlm.nih.gov/pubmed/34863608 http://dx.doi.org/10.1016/j.jsat.2021.108641 |
Ejemplares similares
-
Development and evaluation of a community-based buprenorphine treatment intervention
por: Fox, Aaron D., et al.
Publicado: (2017) -
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19
por: Joseph, Giliane, et al.
Publicado: (2021) -
“It doesn’t make any sense to even try”: the disruptive impact of COVID-19’s first wave on people with chronic pain using medical cannabis in New York
por: Zolotov, Yuval, et al.
Publicado: (2023) -
Bloodstream infections in hospitalized patients before and during the COVID-19 surge in a community hospital in the South Bronx
por: Afzal, Afsheen, et al.
Publicado: (2022) -
Access to and Payment for Office-Based Buprenorphine Treatment in Ohio
por: Parran, Theodore V, et al.
Publicado: (2017)